Sotalol Hcl 150mg/10ml Inj, 10ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
In the event that you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Avoid activities that could lead to dehydration or electrolyte imbalances (e.g., excessive sweating, prolonged vomiting/diarrhea) as these can increase risks.
- Report any symptoms of dizziness, fainting, or very slow heart rate immediately.
- Do not stop taking sotalol suddenly without consulting your doctor, as this can worsen heart conditions.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Severe dizziness or fainting
Chest pain or pressure
Abnormal heartbeat, including a fast or slow heartbeat, or a new or worsening irregular heartbeat
Excessive sweating
Changes in vision
Erectile dysfunction
Heart failure, which can occur even if you have no prior history of heart disease. If you have a history of heart disease, inform your doctor. Seek immediate medical attention if you experience:
+ Shortness of breath
+ Sudden weight gain
+ Abnormal heartbeat
+ New or worsening swelling in the arms or legs
Injection site reactions, such as pain, irritation, or swelling
Other Possible Side Effects
Like all medications, this drug can cause side effects, although not everyone will experience them. If you encounter any of the following side effects or any other symptoms that concern you or do not resolve, contact your doctor or seek medical attention:
Dizziness, fatigue, or weakness
Headache
Diarrhea, nausea, or vomiting
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or fainting spells (syncope)
- Very slow heart rate (bradycardia)
- Shortness of breath or swelling in ankles/feet (signs of heart failure)
- New or worsening palpitations or irregular heartbeats
- Unusual fatigue or weakness
Before Using This Medicine
It is essential to inform your doctor about the following conditions to ensure safe treatment:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Asthma or other lung and breathing problems that cause shortness of breath or wheezing
+ Heart failure (a weak heart)
+ Abnormal heart rhythms, including heart block or sick sinus syndrome
+ A slow heartbeat
Low levels of potassium or magnesium in your blood
If you are taking medications for an irregular heartbeat
If you are taking any medications that can cause a prolonged QT interval, a specific type of abnormal heartbeat. There are many medications that can cause this condition, so be sure to ask your doctor or pharmacist if you are unsure.
Additionally, if you are breast-feeding, please note that you should not breast-feed while taking this medication.
To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter medications you are taking
Any natural products or vitamins you are using
Your complete medical history
Do not start, stop, or change the dose of any medication without first consulting your doctor to confirm that it is safe to do so. This will help prevent potential interactions and ensure the safe use of this medication.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require you to be alert. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and be cautious when climbing stairs.
Monitoring Your Condition
Follow your doctor's instructions for checking your blood pressure and heart rate. Additionally, have your blood work checked as directed by your doctor. Discuss any concerns or questions with your doctor.
Electrocardiogram (ECG) Monitoring
You will need to undergo an ECG before starting this medication and during treatment. Consult with your doctor about this requirement.
Impact on Lab Tests
This medication may affect certain lab tests. Inform all your healthcare providers and lab personnel that you are taking this medication.
Low Blood Sugar Risk
This medication may mask symptoms of low blood sugar, such as a rapid heartbeat, which can increase the risk of severe or prolonged low blood sugar. This risk is higher in people with diabetes, children, and those who are fasting, undergoing surgery, or experiencing vomiting. If you have questions or concerns, discuss them with your doctor.
Diabetes Management
If you have high blood sugar (diabetes), closely monitor your blood sugar levels.
Fluid Loss and Electrolyte Imbalance
Inform your doctor if you experience fluid loss, excessive sweating, vomiting, diarrhea, decreased appetite, or unusual thirst.
Stopping the Medication
Do not stop taking this medication abruptly, as this can lead to worsened chest pain or even a heart attack, especially if you have certain types of heart disease. To minimize side effects, your doctor will instruct you on how to gradually stop taking this medication. Seek immediate medical attention if you experience new or worsening chest pain or other heart problems.
Overactive Thyroid
This medication may make it more challenging to recognize symptoms of an overactive thyroid, such as a rapid heartbeat. If you have an overactive thyroid and stop taking this medication suddenly, your condition may worsen and become life-threatening. Consult with your doctor about this risk.
Allergic Reactions
If you have a history of severe allergic reactions, discuss this with your doctor, as you may be at risk of an even more severe reaction. If you use epinephrine to treat severe allergic reactions, inform your doctor, as this medication may reduce the effectiveness of epinephrine.
Gender-Specific Risks
Female patients may be at a higher risk of side effects. Discuss this with your doctor.
Pregnancy and Breastfeeding
If you are pregnant or plan to become pregnant, consult with your doctor to weigh the benefits and risks of taking this medication during pregnancy.
Overdose Information
Overdose Symptoms:
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Bronchospasm
- Hypoglycemia
- Cardiogenic shock
- Asystole
- Torsade de Pointes
What to Do:
Call 1-800-222-1222 (Poison Control). Treatment is supportive and symptomatic. May include atropine for bradycardia, isoproterenol, glucagon, IV fluids, vasopressors for hypotension, external pacing, and magnesium for TdP. Hemodialysis can remove sotalol.
Drug Interactions
Contraindicated Interactions
- Class Ia antiarrhythmics (e.g., disopyramide, quinidine, procainamide)
- Class III antiarrhythmics (e.g., amiodarone, dronedarone)
- Other drugs that prolong the QT interval (e.g., phenothiazines, tricyclic antidepressants, macrolide antibiotics, fluoroquinolones, cisapride, bepridil)
- Drugs that cause hypokalemia or hypomagnesemia (e.g., loop diuretics, thiazide diuretics, laxatives, amphotericin B IV) unless electrolyte imbalance is corrected
- Calcium channel blockers (e.g., verapamil, diltiazem) due to risk of severe bradycardia, AV block, and hypotension
- Other beta-blockers
Major Interactions
- Digoxin (increased risk of bradycardia, AV block)
- Insulin and oral hypoglycemics (masking of hypoglycemia symptoms)
- Clonidine (exacerbation of rebound hypertension upon withdrawal of clonidine)
- Reserpine, guanethidine (additive hypotensive and bradycardic effects)
- Neuromuscular blockers (prolongation of block)
Moderate Interactions
- NSAIDs (may reduce hypotensive effect)
- Sympathomimetics (e.g., epinephrine, norepinephrine, isoproterenol) (attenuation of beta-agonist effects, risk of hypertension and bradycardia)
- Cimetidine, ranitidine (may increase sotalol levels slightly)
Minor Interactions
- Antacids (may reduce oral sotalol absorption, but not relevant for IV)
Monitoring
Baseline Monitoring
Rationale: To assess baseline QTc interval, heart rate, and identify pre-existing conduction abnormalities. QTc must be <450 ms (or <500 ms in patients with intraventricular conduction delays) before initiation.
Timing: Prior to first dose
Rationale: Hypokalemia and hypomagnesemia increase the risk of Torsade de Pointes. Must be corrected prior to initiation.
Timing: Prior to first dose
Rationale: Sotalol is primarily renally eliminated; dose adjustment is required for renal impairment.
Timing: Prior to first dose
Rationale: To assess baseline cardiovascular status and identify contraindications (e.g., bradycardia, hypotension).
Timing: Prior to first dose
Routine Monitoring
Frequency: Before each dose for the first 3 days of initiation/titration, then periodically (e.g., monthly or as clinically indicated) during maintenance.
Target: QTc <500 ms (or <520 ms in patients with intraventricular conduction delays)
Action Threshold: Discontinue if QTc âĨ500 ms (or âĨ520 ms in patients with intraventricular conduction delays) or if Torsade de Pointes occurs. Consider dose reduction if QTc significantly prolongs.
Frequency: Periodically, especially if on diuretics or with GI losses.
Target: Potassium 4.0-5.0 mEq/L, Magnesium 1.8-2.5 mg/dL
Action Threshold: Correct imbalances promptly.
Frequency: Daily during initiation/titration, then periodically.
Target: Heart rate >50 bpm, SBP >90 mmHg
Action Threshold: Hold dose for bradycardia (<50 bpm) or significant hypotension.
Frequency: Periodically, especially in elderly or those with changing renal function.
Target: Not applicable (used for dose adjustment)
Action Threshold: Adjust dose or discontinue based on CrCl.
Symptom Monitoring
- Palpitations
- Dizziness
- Lightheadedness
- Syncope
- Shortness of breath
- Swelling of ankles/feet
- Chest pain
- Fatigue
- Signs of new or worsening arrhythmia (e.g., irregular heartbeat, skipped beats)
Special Patient Groups
Pregnancy
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Sotalol crosses the placenta. Neonates of mothers treated with sotalol near term may experience bradycardia, hypoglycemia, and respiratory depression.
Trimester-Specific Risks:
Lactation
Sotalol is excreted into breast milk. The American Academy of Pediatrics considers sotalol to be compatible with breastfeeding, but infant monitoring for bradycardia, hypoglycemia, and other beta-blocker effects is recommended, especially in preterm or neonates.
Pediatric Use
Safety and efficacy in pediatric patients have not been established for the IV formulation. Oral sotalol is used in pediatric patients for certain arrhythmias, but dosing is complex and requires specialized expertise.
Geriatric Use
Elderly patients may have reduced renal function, requiring dose adjustment. They may also be more susceptible to adverse effects like bradycardia, hypotension, and proarrhythmia. Careful monitoring of QTc, heart rate, blood pressure, and renal function is crucial.
Clinical Information
Clinical Pearls
- Sotalol has both beta-blocking and Class III antiarrhythmic properties, making it unique.
- Always initiate or re-initiate sotalol in a hospital setting with continuous ECG monitoring for at least 3 days (or 6 doses) to monitor for QTc prolongation and proarrhythmia.
- Correct hypokalemia and hypomagnesemia prior to and during sotalol therapy to minimize TdP risk.
- Renal function is critical for dosing; significant dose reduction or contraindication applies to impaired renal function.
- Avoid concomitant use with other QT-prolonging drugs or drugs that cause electrolyte imbalances.
- Do not abruptly discontinue sotalol, especially in patients with ischemic heart disease, due to risk of exacerbation of angina or myocardial infarction.
Alternative Therapies
- Amiodarone (Class III antiarrhythmic)
- Dofetilide (Class III antiarrhythmic)
- Flecainide (Class Ic antiarrhythmic)
- Propafenone (Class Ic antiarrhythmic)
- Beta-blockers (e.g., metoprolol, carvedilol) for rate control
- Calcium channel blockers (e.g., diltiazem, verapamil) for rate control